Squarepoint Ops LLC Akebia Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

  • $62.8 Billion
  • Q3 2024

A detailed history of Squarepoint Ops LLC transactions in Akebia Therapeutics, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 140,167 shares of AKBA stock, worth $250,898. This represents 0.0% of its overall portfolio holdings.

Number of Shares
140,167
Previous 38,555 263.55%
Holding current value
$250,898
Previous $39,000 374.36%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$0.94 - $1.55 $95,515 - $157,498
101,612 Added 263.55%
140,167 $185,000
Q2 2024

Aug 14, 2024
SELL
$0.86 - $1.63 $185,853 - $352,257
-216,109 Reduced 84.86%
38,555 $39,000
Q1 2024

May 15, 2024
BUY
$1.27 - $2.24 $284,617 - $502,001
224,108 Added 733.43%
254,664 $466,000
Q4 2023

Feb 14, 2024
BUY
$0.8 - $1.28 $24,444 - $39,111
30,556 New
30,556 $37,000
Q2 2022

Aug 15, 2022
SELL
$0.32 - $0.67 $9,224 - $19,312
-28,825 Reduced 49.45%
29,471 $10,000
Q1 2022

May 16, 2022
BUY
$0.72 - $2.93 $23,071 - $93,888
32,044 Added 122.06%
58,296 $42,000
Q4 2021

Feb 14, 2022
BUY
$2.26 - $3.34 $59,329 - $87,681
26,252 New
26,252 $59,000
Q2 2021

Aug 16, 2021
SELL
$2.83 - $4.2 $676,019 - $1 Million
-238,876 Closed
0 $0
Q1 2021

May 17, 2021
SELL
$2.92 - $5.06 $525,319 - $910,314
-179,904 Reduced 42.96%
238,876 $809,000
Q4 2020

Feb 16, 2021
SELL
$2.22 - $3.78 $1.35 Million - $2.29 Million
-606,616 Reduced 59.16%
418,780 $1.17 Million
Q3 2020

Nov 16, 2020
BUY
$2.39 - $13.08 $2.23 Million - $12.2 Million
931,780 Added 995.32%
1,025,396 $2.57 Million
Q2 2020

Aug 14, 2020
SELL
$6.67 - $13.58 $850,378 - $1.73 Million
-127,493 Reduced 57.66%
93,616 $1.27 Million
Q1 2020

May 15, 2020
BUY
$4.1 - $10.24 $442,754 - $1.11 Million
107,989 Added 95.46%
221,109 $1.68 Million
Q4 2019

Feb 14, 2020
SELL
$3.16 - $6.73 $168,756 - $359,408
-53,404 Reduced 32.07%
113,120 $715,000
Q3 2019

Nov 14, 2019
SELL
$3.55 - $5.4 $420,749 - $640,013
-118,521 Reduced 41.58%
166,524 $653,000
Q2 2019

Aug 14, 2019
BUY
$4.1 - $8.05 $715,462 - $1.4 Million
174,503 Added 157.86%
285,045 $1.38 Million
Q1 2019

May 15, 2019
SELL
$5.41 - $8.73 $256,774 - $414,351
-47,463 Reduced 30.04%
110,542 $905,000
Q4 2018

Feb 14, 2019
BUY
$5.39 - $9.15 $394,235 - $669,249
73,142 Added 86.19%
158,005 $874,000
Q3 2018

Nov 14, 2018
BUY
$7.44 - $10.65 $34,841 - $49,873
4,683 Added 5.84%
84,863 $749,000
Q2 2018

Aug 14, 2018
BUY
$9.15 - $11.34 $259,677 - $321,829
28,380 Added 54.79%
80,180 $800,000
Q1 2018

May 15, 2018
BUY
$9.53 - $15.68 $133,381 - $219,457
13,996 Added 37.02%
51,800 $494,000
Q4 2017

Feb 14, 2018
BUY
$14.24 - $19.59 $538,328 - $740,580
37,804
37,804 $562,000

Others Institutions Holding AKBA

# of Institutions
121
Shares Held
54.8M
Call Options Held
291K
Put Options Held
179K
View Full List

About Akebia Therapeutics, Inc.

AKBA Quotes by TradingView
  • Ticker AKBA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 183,848,992
  • Market Cap $329M
  • Description
  • Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics for patients with kidney diseases. The company's lead product investigational product candidate is vadadustat, an oral therapy, which is in Phase III development for the treatment of anemia due to chronic kidney disease (CKD) ...
More about AKBA
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email